Michael Knappik
@michael-knappik.bsky.social
ID specialist HIV/Tb 🩻🧫
Reposted by Michael Knappik
“We call on countries and the WHO to demand pharmaceutical corporations make these key diabetes treatments available in-country by immediately registering them and – critically – making them affordable.”
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
MSF responds to inclusion of rapid-acting insulin analogues and GLP-1s to WHO Essential Medicines List
MSF welcomes inclusion of key diabetes medicines to WHO EML, and calls for countries and WHO to demand corporations make them available and affordable.
msfaccess.org
September 5, 2025 at 2:41 PM
“We call on countries and the WHO to demand pharmaceutical corporations make these key diabetes treatments available in-country by immediately registering them and – critically – making them affordable.”
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
Reposted by Michael Knappik
Hey @novonordisk.bsky.social, all #insulin pens must be available at $1 per pen, so that everyone can access the highest standard of diabetes treatment, especially as their cost of production is estimated to be as low as $0.94 per pen, including a profit.
June 12, 2025 at 3:39 PM
Hey @novonordisk.bsky.social, all #insulin pens must be available at $1 per pen, so that everyone can access the highest standard of diabetes treatment, especially as their cost of production is estimated to be as low as $0.94 per pen, including a profit.
Reposted by Michael Knappik
Time and again, Big Pharma has contested experts-backed generic price studies. Today’s drop in Bedaquiline’s price ($90), bringing it closer to its targeted generic price, is a proof that Pharmaceutical companies must stop profiteering off people's lives.
February 7, 2025 at 3:39 PM
Time and again, Big Pharma has contested experts-backed generic price studies. Today’s drop in Bedaquiline’s price ($90), bringing it closer to its targeted generic price, is a proof that Pharmaceutical companies must stop profiteering off people's lives.